ProHealth health Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Missing protein explains link between obesity, diabetes

Fish oil use associated with brain volume preservation

The Brain Boosting and Fatigue Fighting B-12

Genetic basis for distinct type of autism uncovered

Genetic study suggests causal link between vitamin D deficiency and hypertension

Unsuspected aspect of immune regulation revealed: Role of B cells

IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders

Explaining 'Healthy' Obesity

Sinus Congestion and Sinusitis, Healing Naturally

In the gut, immunity is a two-way street

 
Print Page
Email Article

When Memory Problems are Medication Problems, Not Your Age

  [ 29 votes ]   [ Discuss This Article ]
www.ProHealth.com • November 14, 2012


“All sleeping pills, 1st generation antihistamines and tricyclic antidepressants should be avoided at all costs in seniors.”American Geriatric Society

After age 65, up to 90% of people take at least one prescription medication - and 18% of them complain of memory problems and are found to have mild cognitive deficits. Now new research led by Cara Tannenbaum, MD, a geriatric pharmacologist at the University of Montreal, suggests a frequent link between the two.

Dr. Tannenbaum recently led an international research team to investigate which medications are most likely to affect brain functions that are:

• Amnestic (involve memory)

• Or non-amnestic (involve attention, concentration, cognitive performance).

After analyzing the results from 162 experiments on medications with the potential to bind to cholinergic, histamine, GABA-ergic or opioid receptors in the brain, the team concluded that:

“The episodic use of several [types of] medications can cause amnestic or non-amnestic deficits.”

This potential cause is often overlooked in persons who are otherwise in good health, Dr. Tannenbaum notes. (And may affect younger adults as well, though the research has focused on older people, who take more of these meds, often several of them, and typically for extended periods, even years.)

• The 68 trials on benzodiazepines (which are often used to treat anxiety and insomnia) that were analyzed showed that these drugs consistently lead to impairments in memory and concentration, with a clear dose-response relationship. Higher dose, more effect.

• The 12 tests on antihistamines and the 15 tests on tricyclic antidepressants showed deficits in attention and information processing.

Overall, the study report, published in the journal Drugs & Aging, concludes, “Non-amnestic mild cognitive deficits are consistently induced by first-generation antihistamines and tricyclic antidepressants, while benzodiazepines provoke combined amnestic and non-amnestic impairments.” [A list of first-generation antihistamines/brand names sold over the counter as allergy, cold, and sleep aids can be found here.]

These findings support the American Geriatrics Society’s admonition published in its 2012 Revised Beers Criteria that “All sleeping pills, 1st generation antihistamines and tricyclic antidepressants should be avoided at all costs in seniors.”

Discuss with Your Pharmacist, and Physician

“Patients need this information so that they are more comfortable talking to their doctors and pharmacists about safer pharmacological or non-pharmacological treatment options," Dr. Tannenbaum explains.

And "seniors can play an important role in reducing the risks associated with these medications,” she says. Risks that extend beyond memory problems to include traffic accidents and falls.

She also points out that each case must be addressed on an individual basis: "Despite the known risks, it may be better for some patients to continue their medication instead of having to live with intolerable symptoms. Each individual has a right to make an informed choice based on preference and a thorough understanding of the effects the medications may have on their memory and function."

To physicians, the advice is to discuss risk-benefit considerations with patients “in order to enable an informed choice about drug discontinuation or substitution to potentially reverse cognitive adverse effects.”

Study Detail

This research was conducted in collaboration with researchers at the University of Sydney, the University of Calgary and the University of Iowa College of Public Health.

MEDLINE and EMBASE were searched for randomized, double-blind, placebo-controlled trials of adults without underlying central nervous system disorders who underwent detailed neuropsychological testing prior to and after oral administration of drugs affecting cholinergic, histaminergic, GABAergic or opioid receptor pathways. Seventy-eight studies were identified, reporting 162 trials testing medication from the four targeted drug classes. Two investigators independently appraised study quality and extracted relevant data on the occurrence of amnestic, non-amnestic or combined cognitive deficits induced by each drug class. Only trials using validated neuropsychological tests were included. Quality of the evidence for each drug class was assessed based on consistency of results across trials and the presence of a dose-response gradient.

Source: Based on University of Montreal news release, Nov 6, 2012

___

Note: This information has not been evaluated by the FDA. It is general information, is not intended to diagnose, treat or cure any illness, condition or disease, and must not take the place of the personal attention of a professional pharmacist or healthcare professional. It is very important that you make no change in your healthcare plan or health support regimen without researching and discussing it with your professional healthcare team.




Discuss This Article Post a Comment 




[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Live Longer: Groundbreaking Research on Omega-3s Live Longer: Groundbreaking Research on Omega-3s
Running on Empty? Fuel Up with NADH Running on Empty? Fuel Up with NADH
Sweet Tips for Fibromyalgia Success Sweet Tips for Fibromyalgia Success
Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing